Literature DB >> 32278478

A Review of Cervical Cancer: Incidence and Disparities.

Ama Buskwofie1, Gizelka David-West1, Camille A Clare2.   

Abstract

BACKGROUND: Cervical cancer is the fourth most common cancer amongst women worldwide. In the United States, its incidence and mortality have been declining due to the wide scale implementation of cytological screening programs. However, there have been geographic disparities in cervical cancer, particularly in the US.
OBJECTIVE: This review will outline the overall incidence of cervical cancer and discuss the causes for disparities in its incidence and mortality rates.
METHODS: A literature review was performed from 1999 to 2020 of English language manuscripts on the incidence and reasons for disparities in mortality rates of cervical cancer.
RESULTS: Racial and ethnic minorities, socioeconomically disenfranchised, and those in rural areas have disparate rates of vaccination, screening and treatment of cervical cancer, leading to worse outcomes.
CONCLUSIONS: By addressing these disparities via increased education, access to care, and the expansion of screening and vaccination programs, reductions in cervical cancer incidence and mortality may be achieved.
Copyright © 2020 National Medical Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Disparities; Incidence; Mortality

Mesh:

Year:  2020        PMID: 32278478     DOI: 10.1016/j.jnma.2020.03.002

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  47 in total

1.  Application of vincristine and cisplatin combined with intensity-modulated radiation therapy in the treatment of patients with advanced cervical cancer.

Authors:  Heling Zhang; Ye Zhang
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  Positron Emission Tomography-Guided Bone Marrow-Sparing Radiation Therapy for Locoregionally Advanced Cervix Cancer: Final Results From the INTERTECC Phase II/III Trial.

Authors:  Casey W Williamson; Igor Sirák; Ronghui Xu; Lorraine Portelance; Lichun Wei; Rafal Tarnawski; Umesh Mahantshetty; Elena S Heide; Catheryn M Yashar; Michael T McHale; Walter Bosch; Jessica Lowenstein; Cheryl C Saenz; Steve Plaxe; Ramez Eskander; John Einck; Arno J Mundt; Jyoti Mayadev; Loren K Mell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-08-20       Impact factor: 7.038

3.  Long intergenic noncoding RNA LINC01287 drives the progression of cervical cancer via regulating miR-513a-5p/SERP1.

Authors:  Yixiang Hu; Wenyou Zhang; Zheng Liu; Qichang Xing; Renzhu Liu; Qingzi Yan; Wencan Li; Xiang Liu
Journal:  Hum Cell       Date:  2022-07-27       Impact factor: 4.374

Review 4.  Improving cervical cancer screening rates: a scoping review of resources and interventions.

Authors:  Madyson L Popalis; Sarah I Ramirez; Kelsey M Leach; Marni E Granzow; Kelsey C Stoltzfus; Jennifer L Moss
Journal:  Cancer Causes Control       Date:  2022-08-18       Impact factor: 2.532

5.  Multiparametric immune profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: an exploratory study of the CLAP trial.

Authors:  Yin Wang; Yuerong Lai; Chongjie Tong; Xin Huang; Hongyu Peng; Shumei Yan; Zhimin Liu
Journal:  Clin Transl Oncol       Date:  2022-09-17       Impact factor: 3.340

6.  Multi-Omics Approaches Identify Necroptosis‑Related Prognostic Signature and Associated Regulatory Axis in Cervical Cancer.

Authors:  JuanMei Zhan; Fenfang Yang; Cenhong Ge; Xiaojia Yu
Journal:  Int J Gen Med       Date:  2022-05-13

7.  GLTP Is a Potential Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Cervical Cancer.

Authors:  Yan-Long Shi; Ming-Bo Liu; Hong-Ting Wu; Ye Han; Xuan He
Journal:  Dis Markers       Date:  2022-07-07       Impact factor: 3.464

8.  Acceptability of Human Papilloma Virus Self-Sampling for Cervical Cancer Screening in a Cohort of Patients from Romania (Stage 2).

Authors:  Mihaela Grigore; Ingrid-Andrada Vasilache; Petru Cianga; Daniela Constantinescu; Odetta Duma; Roxana Daniela Matasariu; Ioana-Sadiye Scripcariu
Journal:  J Clin Med       Date:  2022-04-29       Impact factor: 4.964

9.  Application effect of sevoflurane combined with remifentanil intravenous inhalation anesthesia in patients undergoing laparoscopic radical resection of cervical cancer.

Authors:  Xiaoyan Suo; Zhaofei Wang; Yongfeng Zhu
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

10.  PMEPA1 Serves as a Prognostic Biomarker and Correlates with Immune Infiltrates in Cervical Cancer.

Authors:  Jing Li; Wei-Min Kong
Journal:  J Immunol Res       Date:  2022-04-20       Impact factor: 4.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.